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Background: Pluchea indica (L.) Less. (Asteraceae) is a perennial shrub plant with anti-inflammatory and antioxidant
medicinal properties. However, the anti-cancer properties of its aqueous extracts have not been studied. The aim of
this study was to investigate the anti-proliferation, anti-migration, and pro-apoptotic properties of crude aqueous
extracts of P. indica leaf and root on human malignant glioma cancer cells and human cervical cancer cells, and the
underlying molecular mechanism.
Methods: GBM8401 human glioma cells and HeLa cervical carcinoma cells were treated with various concentrations of
crude aqueous extracts of P. indica leaf and root and cancer cell proliferation and viability were measured by cell growth
curves, trypan blue exclusions, and the tetrazolium reduction assay. Effects of the crude aqueous extracts on focus
formation, migration, and apoptosis of cancer cells were studied as well. The molecular mechanism that contributed to
the anti-cancer activities of crude aqueous extracts of P. indica root was also examined using Western blotting analysis.
Results: Crude aqueous extracts of P. indica leaf and root suppressed proliferation, viability, and migration of GBM8401
and HeLa cells. Treatment with crude aqueous extracts of P. indica leaf and root for 48 hours resulted in a significant 75%
and 70% inhibition on proliferation and viability of GBM8401 and HeLa cancer cells, respectively. Crude aqueous extracts
of P. indica root inhibited focus formation and promoted apoptosis of HeLa cells. It was found that phosphorylated-p53
and p21 were induced in GBM8401 and HeLa cells treated with crude aqueous extracts of P. indica root. Expression of
phosphorylated-AKT was decreased in HeLa cells treated with crude aqueous extracts of P. indica root.
Conclusion: The in vitro anti-cancer effects of crude aqueous extracts of P. indica leaf and root indicate that it has
sufficient potential to warrant further examination and development as a new anti-cancer agent.
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Cancer is a prevalent medical problem with high mor-
tality and wide epidemiology [1,2]. It is a complex dis-
ease caused by numerous factors ranging from external
environmental chemicals to hereditary genetics. Current
treatment of cancer can be categorized into three
groups: surgery, chemotherapy, and radiation therapy
[3-5]. Surgical removal of tumor and cancerous growth
can effectively treat 50% of cancer but cannot eliminate* Correspondence: clcho@faculty.nsysu.edu.tw
2Department of Biological Sciences, National Sun Yat-sen University,
Kaohsiung, Taiwan
Full list of author information is available at the end of the article
© 2012 Cho et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orall cancer cells, which results in high recurrence rate [4].
Chemotherapy and radiation therapy have the potential
of removing all cancer cells but both lack the specificity
to limit their damaging effect on cancer cells, thus harm-
ing normal body cells in the process and causing count-
less side-effects. Many chemotherapy chemicals target
proliferating and high-metabolic cells, prominent charac-
teristics of cancer cell and other fast-dividing cells, such
as those of the integumentary system. The focal point of
cancer research is still the search for effective and spe-
cific anti-cancer treatments [6].
The use of complementary and alternative therapies
for cancer patients have grown in developed countries. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the use of herbal products to be 13% to 63% among can-
cer patients [7]. A systematic review found that hypnosis,
imagery, support groups, acupuncture, and healing touch
seemed promising in relieving cancer pain in the short
term; however, no formal recommendation can be made
because of a paucity of rigorous randomized controlled
trials [8]. In a study on the use of complementary and al-
ternative medicine (CAM) by breast cancer survivors in
Ontario, Canada, the investigators found that 66.7% of
the respondents in a randomized survey reported using
CAM [9]. The study concluded that CAM use is com-
mon among Canadian breast cancer survivors and that
many are discussing CAM therapy options with their
physicians [9]. A meta-analysis of randomized trials for
combined Astragalus-based herbs and platinum-based
chemotherapy, as compared to platinum-based chemo-
therapy alone, for advanced non-small-cell lung cancer
found that Astragalus-based herbal medicine may in-
crease effectiveness of platinum-based chemotherapy;
however, rigorous controlled trials are required to con-
firm these results [10]. Thus, herbal medicine is emer-
ging to play an important role in cancer treatment and
survivor therapies.
Pluchea indica (Asteraceae) is a perennial shrub
plant indigenous to many Asian countries [11]. Anti-
inflammatory properties were found in the methanolic
fraction of the chloroform extract of P. indica root
[12]. The methanolic extract of P. indica root was found
to possess the ability to neutralize viper venom and
counter venom-induced lethality and hemorrhagic activ-
ity [13]. Significant anti-ulcer and anti-tuberculosis activ-
ities were found in the methanol fraction of P. indica
root and leaf extracts, respectively [14,15].
This is the first study to demonstrate the in vitro
anti-cancer property of P. indica aqueous extracts in
the inhibition of cancer cell proliferation, focus for-
mation, and migration. It was demonstrated that
crude aqueous extracts of P. indica root effectively
inhibited cancer cell proliferation, focus formation,
and migration at low concentrations (100–300 μg/ml).
Additionally, the underlying mechanism of anti-cancer
activities may be attributed to the induction of critical
tumor suppressor molecules, phosphorylated-p53 and
p21, and decreased expression of an important survival
signaling molecule, phosphorylated-AKT, in GBM8401
and HeLa cancer cells treated with crude aqueous
extracts of P. indica root.
Methods
Cell culture
Human brain malignant glioma cell line GBM8401, and
human cervical carcinoma cell line HeLa were used.
GBM8401 was cultured in RPMI1640 (Invitrogen). HeLawas cultured in Dulbecco’s modified Eagle’s medium
(DMEM). Both RPMI1640 and DMEM were made into
complete medium with 10% cosmic calf serum (CCS;
Hyclone), 200 mM L-glutamine (Invitrogen), 1% Penicil-
lin (10000 units/ml)/Streptomycin (10000 units/ml)
(Hyclone), 1X non-essential amino acids (NEAA; Invitro-
gen), 1 mM sodium pyruvate (Invitrogen). Cells were incu-
bated at 37°C, in a humidified incubator with 5% CO2.
Preparation of Pluchea indica crude aqueous extracts
Live plant material of P. indica was collected from
the Yanchiao campus of National Kaohsiung Normal
University, Kaohsiung, Taiwan. The plant material was
authenticated and prepared as root and leaf dry powder
by Professor L J Liao. The extraction of crude aqueous
extracts of P. indica leaf or root was prepared by the
method of Li et al. [16]. Briefly, 25 g of leaf or root
powder were extracted three times in 200 ml of ddH2O
(75°C-80°C) on a shaker. The resultant aqueous solu-
tion, which was filtered through 0.45-μm filters, was
further concentrated by quickly frozen at −40°C and
dried for 48 h using a freeze dryer (Savant Refrigerated
vapor Trap, RV T41404, USA) to give a yield of 2.2 g
crude leaf extracts (12.5%) and 1.3 g of crude root
extracts (9.9%), respectively. The soluble aqueous
extracts were dissolved in ddH2O to obtain stock solu-
tions of P. indica leaf or root aqueous extract. Different
desired concentrations of crude aqueous extracts were
prepared by reconstitution with ddH2O and used in
this study.
Preliminary phytochemical screening of Pluchea indica
crude aqueous extracts
The P. indica dry crude extract was evaluated for total phe-
nol and flavonoids contents using Folin-Ciocalteu reagent
and the aluminum chloride colorimetric method and was
calculated as gallic acid equivalents in mg/g of extract and
catechin equivalents in mg/g of extract, respectively,
according to methods described previously with minor
modifications [17]. Proanthocyanidins content was deter-
mined using the vanillin assay and expressed as catechin
equivalents in mg/g of extract as described by Butler et al.
[18]. All assays were carried out in triplicate.
Determination of lipid peroxidation
Lipid peroxidation was measured in HeLa cells using the
thiobarbituric acid (TBA) assay for malondialdehyde and
normalized to total protein [19]. Briefly, cell pellets were
mixed with 0.3% deaerated thiobarbituric acid solution
in 3.9% (w/v) trichloroacetic acid and incubated at 95–
100°C for 20 min. After cooling, the reaction mixtures
were centrifuged at 10,000 rpm for 10 min. The super-
natants were then loaded in 96-well plates and deter-
mined at an absorbance of 532nm/600nm. The MDA
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extinction coefficient of 155 mM-1 cm-1.
Cell proliferation and viability assays
Trypan blue exclusions and the tetrazolium (3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium; MTS) reduction assay were
used to monitor the proliferation and viability of cancer
cells upon exposure to different concentrations of aque-
ous extracts for different incubation periods. For the
MTS assay, CellTiter 96 Aqueous One Solution Cell
Proliferation Assay Kit (Promega, USA) was used by fol-
lowing manufacturer’s protocol. Briefly, 2 × 103 cells/
well was seeded in 96-well plates. Following a 24-hour
incubation, P. indica leaf or root aqueous extract at 0,
100, 500, and 1000 μg/ml concentrations was added and
incubated for 72 hours. After the 72-hour incubation,
the medium was removed, 100 μl of medium with 20 μl
of MTS solution was added, and the cells were incu-
bated for 3 hours. Absorbance was read at 490 nm with
an ELISA Reader (Micro Quant, BIO-TEK, USA) and
analyzed using the KC4 3.3 Rev 10 program (BIO-TEK
instruments Inc., USA). Trypan blue dye exclusion was
used to assess the viability of cancer cells grown under
different conditions as described above. Growth curves,
each covering a total of 6 days of culturing, were con-
structed from which the effects of P. indica aqueous ex-
tract on population doubling time and saturation density
were determined.
Focus formation assay
One hundred cells were seeded in 60-mm plates and
incubated at 37°C, 5% CO2 for 24 hours. The plates were
prepared in triplicates. Following a 24-hour incubation,
various concentrations of P. indica root aqueous extract
were added. After 10 days, colonies were stained with
crystal violet and counted.
In vitro “scratch” wound closure assay
In vitro wound closure assay was performed as described
previously [20]. In brief, HeLa cells with 90% confluence
were wounded by scraping across the cell monolayer
with a pipette tip. After washing with PBS, cells were
incubated in the media supplemented with aqueous
extracts of P. indica root at 0, 250, and 500 μg/ml con-
centrations, respectively. “Scratch” wound closure of the
scratched surface was observed and photographed at
0-, 24-, 48-, and 72-hour time intervals.
Apoptosis assay and flow cytometry analysis
Determination of apoptosis was conducted following man-
ufacturer’s protocol by staining with FITC Annexin V
Apoptosis Detection Kit I (BD Pharmingen, BD Bios-
ciences, USA). Briefly, cells were plated in 100-mm culturedishes and allowed to grow to 70-80% confluence. They
were treated with appropriate concentrations of aqueous
extract and incubated for 2 days. The cells (1 × 105cells/
100 μl were collected and 5 μl of FITC Annexin V and
5 μl of propidium iodide (PI) were added. Cells were
then incubated in the dark at room temperature. After
15 min, 400 μl of 1 × binding buffer was added to the
cells. Flow cytometry analysis was conducted using BD
LSR II Flow Cytometer (BD). Flow cytometry data were
analyzed using BD FACSDiva software (BD).
Western blot analysis
After treatment with P. indica aqueous extracts, cells
were lysed with T-PER protein extraction reagent
(Pierce), and 20 μg protein was used for immunoblotting
analysis. Immunoblotting proteins were eluted by boiling
for 5 min in a 1 × SDS sample buffer containing 5% (v/v)
2-mercaptoethanol. Proteins were resolved in a 12%
SDS-PAGE and transferred to nitrocellulose membranes.
The nitrocellulose membranes were immunoblotted with
specific antibodies against p21 (Santa Cruz Biotechnology),
phosphorylated-p53 (pS15) (Cell Signaling Technology),
AKT (Cell Signaling Technology), phosphorylated-AKT
(Cell Signaling Technology), Cleaved Caspase-3 (Asp175)
(5A1E) Rabbit mAb (Cell Signaling Technology), α-tubulin
(NeoMarkers), or β-actin (SIGMA), respectively. For
visualization of immunoreactive bands, ECL+ reagents
(Amersham) followed by chemiluminescence were used.
Control and experimental groups were generated from the
same blot.
Statistical analysis
Data are presented as mean ± standard deviations (SD)
of three independent experiments and statistical signifi-
cance was determined using Independent Student’s t-test
and the SPSS 12.0 software (SPSS Inc., USA). A signifi-
cant difference was considered if P < 0.05.
Results
Phytochemical screening
The preliminary phytochemical analysis performed on
crude aqueous extracts of P. indica leaf and root
revealed the presence of tannins, saponins, flavonoids
and proanthocyanidins. The total phenol content of the
crude aqueous extract of P. indica root was 78.9 mg
gallic acid equivalent/g of dry extract with reference to
standard curve (y = 3.5547x - 0.0159, R2 = 0.9997)
(Table 1). The total flavonoids and proanthocyanidins
contents of the plant were 40.4 mg and 4.248 mg cat-
echin equivalent/g of dry extract with reference to
standard curves (y = 0.0038x −0.0075, R2 =0.9997 and
y = 0.0118x + 0.0347, R2 = 0.9924), respectively (Table 1).
The screened phytochemical compounds are known to
support bioactive activities in medicinal plants and thus






MeanN ± SD Percentage in
extract
Flavonoids ++ ND ND
Tannins ++ ND ND
Saponins + ND ND
Total phenol +++ 78.9±0.6 mg GAE/g DW 7.89
Total flavonoids ++ 40.4±0.3 mg CE/g DW 4.04
Proanthocyanidins + 4.248±0.068 mg CE/g
DW
0.42
N=3; +++ = appreciable amount (positive within 3 min.); ++ = moderate
amount (positive after 3 min., but within 5 min.); + = trace amount (positive
after 5 min.); GAE = gallic acid equivalents; CE = catechin equivalents.
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activities of the crude aqueous extracts of P. indica used
in this study.
Membrane lipid oxidation
The levels of lipid peroxidation (thiobarbituric acid reactive
species; TBARS) was indirectly measured by monitoring
the production of MDA equivalents from the oxidation of
malondialdehyde in HeLa cells treated with 0.5 mg/ml of
crude aqueous extracts of P. indica root after 24-hr and
48-hr incubation (Figure 1). A significant increase in MDA
equivalents, which corresponds to an increase of lipid per-
oxide on membranes, was observed for cells incubated for
48-hr with crude aqueous extract. The pro-oxidant activity
of the crude aqueous extracts of P. indica root in HeLa
cancer cells was evident (Figure 1).Figure 1 Pro-oxidant activity of crude aqueous extract of P. indica
root in HeLa cancer cells. Measurement of thiobarbituric acid reactive
species (TBARS) during malondialdehyde peroxidation in HeLa cells
treated with 0.5 mg/ml of crude aqueous extracts at 24-hr and 48-hr
incubation respectively were performed as described in Methods. Each
experiment was done in triplicate. The pro-oxidant activity of the crude
aqueous extract of P. indica root was evident. Data are expressed as
mean ± SD. *P < 0.01.Crude aqueous extracts of P. indica leaf and root
suppress cancer cell growth
High rate of proliferation is a hallmark of cancer cells. To
examine the effect of P. indica leaf and root aqueous
extracts on cancer cell proliferation, growth curve experi-
ments were performed. The inhibitory effect of the ex-
tract treatment was time-dependent (Figure 2). It was
observed that 300 μg/ml of P. indica leaf and root aque-
ous extracts suppressed GBM8401 brain cancer cell
growth at day 6 as compared to untreated cells (P < 0.05)
(Figure 2A). At both day 4 and day 6, the same dosage
(300 μg/ml) of P. indica leaf and root aqueous extracts
inhibited HeLa cervical cancer cell growth as compared
to untreated cells (P < 0.05) (Figure 2B).
Crude aqueous extracts of P. indica leaf and root decrease
proliferation and viability of cancer cells
To further determine the effect of P. indica leaf or root
aqueous extracts on cancer cell proliferation and viabil-
ity, MTS assay was performed. The effect of inhibition by
these extracts was dose-dependent on both types of can-
cer cells (Figure 3). At the 1 mg/ml dose, both leaf and
root extracts were effective, and treatment with 1 mg/ml
for 72 hours resulted in 75% inhibition on GBM8401
brain cancer cells (Figure 3A). As shown in Figure 2B,
treatment with leaf or root extract at the 1 mg/ml dose
also resulted in significant inhibition (70%) of prolifera-
tion and viability of HeLa cells. The results indicated that
P. indica aqueous extracts exerted anti-proliferation ac-
tivity on GBM8401 and HeLa cancer cells.
Crude aqueous extracts of P. indica root inhibits cancer
cell focus formation
Focus formation assay was performed to examine the
inhibitory effect of P. indica root aqueous extract on
proliferation of cancer cells. Ten days after incubation in
10 μg/ml and 100 μg/ml P. indica root aqueous extracts,
GBM8401 cells showed diminished focus formation, and
HeLa cells showed marked decrease in focus formation
after 100 μg/ml P. indica root aqueous extract treat-
ment compared to untreated cells in both cell lines
(Figure 4). When treated with 200 μg/ml P. indica root
aqueous extract, both GBM8401 and HeLa cells showed
nearly zero focus formation when compared to un-
treated cells (Figure 4D,H).
Crude aqueous extracts of P. indica leaf and root
represses cancer cell migration
Many cancer cells exhibit migratory properties, and mi-
gration is essential for cancer cells during metastasis. In
vitro “scratch” wound closure assay was performed to
further examine the inhibitory effect of P. indica leaf or
root aqueous extracts on the migratory activity of cancer
cells. When treated with 250 μg/ml or 500 μg/ml leaf or
Figure 2 Effect of P. indica leaf or root crude aqueous extract on the growth of cancer cells. Growth curves of (A) GBM8401 cells
and (B) HeLa cells after 300 μg/ml P. indica leaf or root aqueous extract treatment. Each experiment was done in triplicate. Data are
expressed as mean ± SD. *P < 0.05.
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tract, less migratory GBM8401 cells were found in the
gap after 72 hours of extract incubation (data not
shown). For HeLa cells, compared to control, less than
50% and 25% migrating cells can be found in the gap
after 48 hours incubation with 250 μg/ml and 500 μg/ml
P. indica root aqueous extract, respectively (Figure 5B,C,
D,E). Thus, P. indica leaf and root aqueous extract, at
concentrations of 250 μg/ml and 500 μg/ml, showed
highly repressive effect on migration of HeLa cells.
P. indica root aqueous extracts induce apoptosis in HeLa
cervical carcinoma cells
The induction of apoptosis in cancer cells is another
characteristic of anti-cancer agents. FITC-annexin V and
propidium iodide (PI) staining assay was performed to
examine the pro-apoptotic potential of P. indica root aque-
ous extract in HeLa cells. Fluorescence microscopy analysis
(Figure 6) demonstrated that significant apoptosis occurredFigure 3 Effect of P. indica leaf or root crude aqueous extract on cell
assay. MTS assay of (A) GBM8401 cells and (B) HeLa cells after 0, 100, 500,
experiment was done in triplicate. Data are expressed as mean ± SD.in HeLa cells treated with crude aqueous root extracts of
P. indica for 48 hours as depicted by stronger staining of
the cells by the Annexin V antibody (green; Figure 6E) as
compared to the control cells (Figure 6B). PI staining (red;
Figure 6F) was also noted, indicating late apoptotic or
necrotic cells. To measure the percentage distribution of
P. indica extract-induced apoptotic and necrotic HeLa
cancer cells, flow cytometry was performed (Figure 7A
and Figure 7B). In control HeLa cells, there was only
0.1% of apoptotic cells (Figure 7A; Quadrant 4–1). After
48 hours of treatment with 0.5 mg/ml P. indica root
aqueous extract, approximately 43% of HeLa cells were
detected as undergoing the end stage of necrosis and
apoptosis (Figure 7B; Quadrant 2-1+Quadrant 4–1). In
addition, activation of caspase-3, which is marked by
cleavage of procaspase-3, is shown by Western blotting
(Figure 7C), which corroborated with results obtained
with fluorescence microscopy (Figure 6) and flow cyto-
metry (Figure 7A and Figure 7B) analysis; caspase 3 isproliferation and viability of cancer cells as determined by MTS
and 1000 μg/ml P. indica leaf or root aqueous extract treatment. Each
Figure 4 Effect of P. indica root crude aqueous extract on the focus formation ability of cancer cells. Focus formation assay of (A, B, C, D)
GBM8401 cells and (E, F, G, H) HeLa cells after P. indica root aqueous extract treatment. (A, E) 0 μg/ml P. indica root aqueous extract treatment.
(B, F) 10 μg/ml P. indica root aqueous extract treatment. (C, G) 100 μg/ml P. indica root aqueous extract treatment. (D, H) 200 μg/ml P. indica root
aqueous extract treatment. Each experiment was repeated five times.
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root aqueous extract at 0.5 mg/ml concentration effect-
ively induced apoptosis/necrosis in HeLa cells.P. indica root aqueous extracts suppress cancer cell
proliferation and migration through the phosphorylated-
p53 and p21 pathways
To elucidate the underlying mechanism in the inhibition of
cancer cell proliferation and migration by P. indica leaf or
root aqueous extracts, Western blots of phosphorylated-
p53 and p21 were examined. Phosphorylated-p53 and p21
were found to be induced in GBM8401 cells treated for 3
days with 1 mg/ml P. indica leaf (lane 6) and root (lane 3)
aqueous extracts (Figure 8A). Phosphorylated-p53 and p21
were found to be induced and phosphorylated-AKT were
found to be decreased in HeLa cells treated for 48 hours
with 0.25 mg/ml and 0.5 mg/ml P. indica root aqueous
extracts (Figure 8B).Figure 5 Effect of P. indica root crude aqueous extract on migration o
assay. “Scratch” wound closure assay of (A) HeLa cells after 0 hours. (B) He
extract. (C) HeLa cells after 48 hours incubation with 250 μg/ml P. ind
with 500 μg/ml P. indica root aqueous extract. (E) Statistical analysis o
P. indica root aqueous extract. Each experiment was done in triplicateDiscussion
This study examined the cell growth arrest, anti-prolif-
eration, anti-migration, and pro-apoptosis properties of
Pluchea indica leaf and root crude aqueous extracts in
human brain malignant glioma cell line GBM8401, and
human cervical carcinoma cell line HeLa. The under-
lying inhibitory mechanism of P. indica leaf and root
crude aqueous extract was also investigated. It was
detected that membrane lipid oxidation level in HeLa
cells increased after treatment with P. indica crude
aqueous extract. The data showed that P. indica leaf and
root crude aqueous extracts were effective in suppres-
sing the proliferation and migration of GBM8401 and
HeLa cells. It was found that P. indica root crude aque-
ous extract inhibited focus formation of GBM8401 and
HeLa cells, and promoted apoptosis in HeLa cells. The
data indicated that phosphorylated-p53 and p21 were
induced in P. indica root crude aqueous extract-treated
GBM8401 and HeLa cells, and that phosphorylated-f HeLa cells as determined by in vitro “scratch” wounjd closure
La cells after 48 hours incubation with 0 μg/ml P. indica root aqueous
ica root aqueous extract. (D) HeLa cells after 48 hours incubation
f HeLa cells after 48 hours incubation with 0, 250, or 500 μg/ml
. Error bars show mean ± SD; bars show means; *P < 0.05.
Figure 6 Fluorescence microscopy of HeLa cells treated with crude aqueous root extracts of P. indica for 48 hours and double stained
with annexin-V-sensitive probe (conjugated to FITC) and propidium iodide. Qualitative labeling of annexin V in the plasma membrane
(B and E) or cellular uptake of propidium iodide (C and F) was recorded. Control cells exposed to PBS (A)-(C), and 0.5 mg/ml of crude aqueous
extracts treated cells (D)-(F) were photographed with a microscope (× 40).
Cho et al. BMC Complementary and Alternative Medicine 2012, 12:265 Page 7 of 11
http://www.biomedcentral.com/1472-6882/12/265AKT was decreased in HeLa cells treated with P. indica
root crude aqueous extract.
The medicinal properties of P. indica extracts have been
studied previously. The methanol fraction of P. indica root
extract was found to possess antioxidant activity [11]. The
methanolic fraction of a chloroform extract of P. indica
root was found to have anti-inflammatory activity [12].
Beta-sitosterol and stigmasterol isolated from P. indica
root methanol extract was found to be able to neutralize
viper and cobra venom and antagonize cobra venom-
induced lethality, cardiotoxicity, neurotoxicity, and respira-
tory changes [13]. In contrast to previous studies, this is
the first study to examine the effect of crude aqueous
extracts of P. indica leaf and root on cancer cells. Tannins,
saponins, flavonoids, phenols, and proanthocyanidins were
detected in crude aqueous extracts of P. indica leaf androot, which showed that P. indica has reasonable anti-
cancer potential because total phenolics, flavonoids, and
tannins were shown to inhibit ATP-binding cassette trans-
ports in cancer cells [21], flavonoid intake was found to as-
sociate with a significant reduction in the risk of gastric
cancer in women [22], saponins from Radix astragali were
found to suppress colon cancer cell carcinogenic activity
by reducing vascular endothelial growth factor [23], and
proanthocyanidins from grape seeds inhibited pancreatic
cancer cell growth and induced apoptosis [24].
Research into the anti-cancer potential of herbal extracts
have been growing and expanding [6,25]. The compound,
n-butylidenephthalide, isolated from the chloroform ex-
tract of Angelica siensis was found to upregulate the ex-
pression of p21 and p27 and increase apoptosis-associated
proteins in DBTRG-05MG and RG2 cells and suppress the
Figure 7 Flow cytometry analysis of HeLa cells stained with FITC-Annexin V and PI and Western blotting of enhanced expression of
cleaved caspase-3. Flow cytometry analysis of FITC-Annexin V and PI stained HeLa cells with untreated HeLa cells (A) and HeLa cells treated
with 0.5 mg/ml P. indica root extract for 48 hours (B). In each scatter plot, upper-left quadrant (Q1-1) shows naked nucleus cell mass, upper-right
quadrant (Q2-1) shows necrotic cell mass, lower-left quadrant (Q3-1) shows survival cell mass, and lower-right (Q4-1) shows apoptotic cell mass.
In control cells, there were only 0.1% of apoptotic cells (Figure 7A; Q4-1). After 48 hours of treatment with 0.5 mg/ml P. indica root aqueous
extract, approximately 43% of cells were detected as undergoing necrosis and apoptosis (Figure 7B; Q2-1+Q4-1). (C) A representative of Western
blotting of time-dependent increasing expression of cleaved caspase-3. Cleaved Caspase-3 (Asp175) monoclonal antibody (5A1E; Cell Signaling
Technology) used detects levels of the large fragment (17/19 kDa) of activated caspase-3 resulting from cleavage adjacent to Asp175. Lane 1:
untreated; lane 2: 1 day of 0.5 mg/ml extract treatment; lane 3: 2 days of 0.5 mg/ml extract treatment; lane 4: 3 days of 0.5 mg/ml extract
treatment. Each experiment was done in triplicate.
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Nexrutine, a Phellodendron amurense bark methanol ex-
tract, was found to inhibit prostate cancer cell proliferation
through modulation of AKT and cAMP-responsive elem-
ent binding protein (CREB)-mediated signaling pathway,
and that Nexrutine activates cyclin D1, which prevents theFigure 8 Western blot analysis of phosphorylated-p53 and p21 prote
extract. (A) Western blot of p21 and phosphorylated-p53 proteins of GBM
days of 0.1 mg/ml P. indica root aqueous extract treatment; lane 3: 3 days of 1
P. indica root aqueous extract treatment; lane 5: 3 days of 0.1 mg/ml P. indica le
aqueous extract treatment. (B) Western blot of p21, phosphorylated-p53, AKT, a
treatment. Lane 1: untreated; lane 2: 2 days of 0.25 mg/ml P. indica root aqueo
extract treatment. Each experiment was done in triplicate.progression of prostate cancer [27]. In this study, it was
observed that P. indica leaf and root aqueous extracts
inhibited GBM8401 malignant glioma cells and HeLa cer-
vical carcinoma cell growth, and migration. We found that
the crude aqueous extract P. indica root suppressed focus
formation of GBM8401 and HeLa cells.ins in cancer cells treated with P. indica leaf or root aqueous
8401 cells after P. indica extract treatment. Lane 1: untreated; lane 2: 3
mg/ml P. indica root aqueous extract treatment; lane 4: 5 days of 1 mg/ml
af aqueous extract treatment; lane 6: 3 days of 1 mg/ml P. indica leaf
nd phosphorylated-AKT proteins of HeLa cells after P. indica extract
us extract treatment; lane 3: 2 days of 0.5 mg/ml P. indica root aqueous
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properly in most human cancers [28]. In brain cancers,
p53 can be inactivated through amino acid-changing
mutation in the DNA-binding domain and/or deletion
of the p14ARF gene, and in cervical cancers, p53 is inacti-
vated through viral infection [29,30]. Phosphorylation of
p53 by kinases, caused by DNA damage, leads to p53 ac-
tivation [31]. Phosphorylation of p53 can also occur in
response to oxidative stress through the platelet-derived
growth factor β receptor (PDGFβ)-mediated ataxia tel-
angiectasia mutated (ATM) kinase activation or direct
ATM activation by oxidative stress [32,33]. One of the
first consequences of p53 activation is cell cycle arrest
through the p53-dependent expression of p21WAF1/CIP1,
an inhibitor of cyclin-dependent kinases (CDKs) [34].
Upregulation of p53 and p21 were found to be
induced by lipid peroxidation in previous studies: lipid
peroxidation increase was associated with p53 mRNA
increase in a rat model [35], lipid peroxidation product
from increased ferrous iron level in lysosomal com-
partment triggered upregulation of p53 [36], lipid per-
oxidation product sensitizes cells to UV-induced killing
by inhibiting nucleotide excision repair and forming a
peroxide-DNA adduct at codon 249 of the p53 gene
[37], and that hydrogen peroxide-induced lipid peroxide
production increased p21 expression [38]. In the present
study, it was observed that P. indica root crude aqueous
extracts caused an increase in membrane lipid oxidation,
and induced phosphorylated-p53 and p21expression in
GBM8401 and HeLa cells.
The AKT/PKB (protein kinase B) kinases play import-
ant roles in signaling pathways that regulate cellular pro-
cesses controlling cell proliferation, survival, and
genome stability [39]. Hyperactivation of the AKT path-
way was implicated in many types of human cancer and
dominantly inherited cancer syndrome. AKT phosphory-
lates and inactivates the pro-apoptotic factors BAD and
procaspase-9 [39]. In a pro-cell cycle progression mech-
anism involving p53, AKT promotes the phosphorylation
and translocation of Mdm2 into the nucleus, where it
downregulates p53, which antagonizes p53-mediated cell
cycle checkpoints [40]. AKT directly antagonizes the
function of the cell cycle inhibitors p21WAF1 and p27Kip1
by phosphorylating a site located near the nuclear
localization signal to induce cytoplasmic retention of
these cell cycle inhibitors [41]. Some investigations have
shown elevated AKT activity to be highly prevalent in
high grade, late stage and/or metastatic tumors, and
several reports have linked AKT activation with reduced
patient survival or tumor radio-resistance [42,43]. In
the present study, P. indica root crude aqueous extract
treatment lowered the expression of activated phos-
phorylated-AKT, without affecting the expression of
non-phosphorylated AKT, and induced the expressionof phosphorylated-p53 and p21 in HeLa cells. There-
fore, the pro-apoptotic and anti-proliferation properties
of the crude aqueous extract of P. indica root might be
attributed to its induction of phosphorylated-p53 and
p21 through the downregulation of activated phos-
phorylated-AKT, which causes cell cycle arrest and ini-
tiation of apoptosis leading to cancer cell death.
The active components in crude aqueous extracts of
P. indica root may be good candidates for further in-
vestigation into the search for effective anti-cancer and
synergistic drugs. It is also important to note that
aqueous extracts of herbal substance was previously
found to be less toxic than ethanol extracts of herbal ma-
terial; the LD50 of aqueous and ethanol extracts were
12.30 g/kg and 6.15 g/kg, respectively [44]. We found
that P. indica leaf and root crude aqueous extracts pos-
sess pro-oxidant, anti-proliferation, and anti-migration
properties in GBM8401 malignant glioma cells and HeLa
cervical carcinoma cells, and that P. indica root crude
aqueous extract inhibited focus formation of these cancer
cells. We also found that phosphorylated-p53 and p21
are induced in GBM8401 and HeLa cells after P. indica
root crude aqueous extracts treatments. As keenly
pointed out by a review, the challenge in CAM is to avoid
contaminated products and those that may interact with
prescription pharmaceuticals [6]. Further examination
into the underlying anti-cancer mechanism and pharma-
codynamic and pharmacokinetic interactions with
current cancer drugs should be carried out to ensure ef-
fective clinical application and usage of P. indica leaf or
root crude aqueous extract.
Conclusions
In conclusion, the results of this study suggest that
P. indica crude aqueous extracts has a promising anti-
proliferative and anti-migratory effect on GBM8401
malignant glioma cells and HeLa cervical carcinoma
cells. In addition, it was found that P. indica crude
aqueous extracts induced critical tumor suppressor
molecules, phosphorylated-p53 and p21, for cell cycle
arrest and apoptosis, and downregulated an import-
ant survival signaling molecule, phosphorylated-AKT.
Further investigations are needed to determine the
entire anti-cancer molecular mechanism of P. indica
aqueous extracts.
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